XVIVO.ST
Price:
$246
Market Cap:
$7.75B
Xvivo Perfusion AB (publ) is a medical technology company that creates and supplies advanced solutions for the preservation and perfusion of organs, tissues, and cells, primarily for use in transplantation. The company's global reach extends across Sweden, the United States, both North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Its product line includes the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass system designed to facilitate safe normothermic ex vivo lung perfusion (EVLP). To support this, the XPS Disposable Lung Kit offers all the necessary sterile, pre-packed components for EVLP procedures. Xvivo also provides STEEN Solution, an...[Read more]
Industry
Medical - Devices
IPO Date
2012-10-08
Stock Exchange
STO
Ticker
XVIVO.ST
According to Xvivo Perfusion AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is 84.83. This represents a change of -36.04% compared to the average of 132.63 of the last 4 quarters.
The mean historical PE Ratio of Xvivo Perfusion AB (publ) over the last ten years is 432.68. The current 84.83 PE Ratio has changed 1.86% with respect to the historical average. Over the past ten years (40 quarters), XVIVO.ST's PE Ratio was at its highest in in the September 2018 quarter at 9.74K. The PE Ratio was at its lowest in in the March 2017 quarter at -11611.84.
Average
432.68
Median
285.08
Minimum
-195.03
Maximum
1.26K
Discovering the peaks and valleys of Xvivo Perfusion AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 415.75%
Maximum Annual PE Ratio = 1.26K
Minimum Annual Increase = -609.99%
Minimum Annual PE Ratio = -195.03
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 233.25 | 160.92% |
| 2024 | 89.40 | -16.71% |
| 2023 | 107.33 | -63.64% |
| 2022 | 295.16 | -70.32% |
| 2021 | 994.64 | -609.99% |
| 2020 | -195.03 | -121.80% |
| 2019 | 894.74 | 225.36% |
| 2018 | 275.00 | -26.71% |
| 2017 | 375.20 | -70.15% |
| 2016 | 1.26K | 415.75% |
The current PE Ratio of Xvivo Perfusion AB (publ) (XVIVO.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
143.33
5-year avg
343.96
10-year avg
432.68
Xvivo Perfusion AB (publ)’s PE Ratio is greater than Swedencare AB (publ) (83.44), greater than CellaVision AB (publ) (24.31), greater than Surgical Science Sweden AB (publ) (29.57), greater than Paxman AB (publ) (-101.45), greater than RaySearch Laboratories AB (publ) (27.43), greater than Implantica AG (-23.61), greater than Arjo AB (publ) (19.30), greater than Stille AB (35.55), greater than BICO Group AB (publ) (-1.01), greater than C-Rad AB (publ) (40.80),
| Company | PE Ratio | Market cap |
|---|---|---|
| 83.44 | $4.09B | |
| 24.31 | $3.26B | |
| 29.57 | $1.55B | |
| -101.45 | $1.11B | |
| 27.43 | $6.08B | |
| -23.61 | $3.71B | |
| 19.30 | $7.46B | |
| 35.55 | $2.21B | |
| -1.01 | $978.10M | |
| 40.80 | $1.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xvivo Perfusion AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Xvivo Perfusion AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Xvivo Perfusion AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Xvivo Perfusion AB (publ) (XVIVO.ST)?
What is the highest PE Ratio for Xvivo Perfusion AB (publ) (XVIVO.ST)?
What is the 3-year average PE Ratio for Xvivo Perfusion AB (publ) (XVIVO.ST)?
What is the 5-year average PE Ratio for Xvivo Perfusion AB (publ) (XVIVO.ST)?
How does the current PE Ratio for Xvivo Perfusion AB (publ) (XVIVO.ST) compare to its historical average?